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Studies on the regulation of hydrogen ion secretion in the collecting duct
in vivo: Evaluation of factors that influence the urine minus blood Pco2
difference. The purpose of these studies was to clarify the basis of the
relationship between the urine bicarbonate concentration and the urine
minus blood Pco2 difference in alkaline urine (U-B Pco2) and hence
shed light on factors that influence hydrogen ion secretion in the
collecting duct in vivo. The U-B Pco2 was used to monitor this latter
parameter. In dogs with a normal extracellular fluid (ECF) volume, the
U-B Pco2 was not primarily influenced by the urine bicarbonate
concentration but rather it was related to the rate of sodium excretion.
The U-B Pco2 could be abolished by amiloride when the urine bicarbon-
ate concentration was less than 60 ms. At higher urine bicarbonate
concentrations, there was a linear correlation between the U-B Pco2
and the urine bicarbonate concentration in normovolemic dogs given
arniloride, but the absolute values were lower than they were in
normovolemic animals not treated with amiloride. In the dogs with an
expanded ECF volume, the U-B Pco was lower than it was in the
normovolemic animals, and the U-B Pco2 was now directly related to
the urine bicarbonate concentration and not influenced by the rate of
sodium excretion, Amiloride had little influence on the U-B Pco2 under
these conditions. These results are interpreted to suggest that the
magnitude of collecting duct hydrogen ion secretion is determined
primarily by the electrical gradient generated by sodium reabsorption in
normovolemic dogs and by the intracellular and lumenal hydrogen ion
concentrations when the ECF volume is expanded or when active
sodium reabsorption is inhibited by amiloride.
Etude de Ia regulation de Ia sécrétion d'ion bydrogene dans le canal
collecteur in vivo: Evaluation des facteurs qui influencent Ia difference de
Pco2 entre l'urine et le sang. Le but de ce travail est de clarifier Ia base
de Ia relation entre la concentration de bicarbonate de l'urine et Ia
difference de Pco2 entre l'urine et le sang en urine alcaline (U-B Pco2)
et par consequent d'identifier les facteurs qui influencent Ia sécrétion
d'ion hydrogène par Ic canal collecteur in vivo. U-B Pco2 a Cté utilisée
pour suivre cc dernier paramètre. Chez des chiens dont le volume
extracellulaire est normal U-B Pco2 n'est pas influencée par Ia concen-
tration de bicarbonate urinaire, mais est plutOt liée au debit d'excrétion
de sodium. U-B Pco2 peut être abolie par l'amiloride quand Ia concen-
tration urinaire de bicarbonate est infCrleure a 60 ms'i. Aux concentra-
tions urinaires de bicarbonate plus élevées, II y a one relation linéaire
entre U-B Pco2 et Ia concentration urinaire de bicarbonate chez des
chiens normovolémiques recevant de l'amiloride, mais les valeurs
absolues sont inférieures a celles des animaux normovolémiques non
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traités par l'amiloride. Chez les chiens dont le volume extracellulaire
est augmentC, Ia difference U-B Pco2 est inférieure a celle des animaux
normovolémiques, directement liée a Ia concentration de bicarbonate
urinaire et non influencée par Ic debit d'excrétion de sodium. L'amilor-
ide a peu d'influence sur U-B Pco2 dans ces conditions. Ces résultats
suggèrent que l'importance de Ia sécrdtion d'ion hydrogene par Ic canal
collecteur est essentiellement déterminée par Ic gradient electrique
engendre par La reabsorption de sodium chez le chien normovolemique
et par les concentrations intracellulaire et luminale d'ion hydrogène
quand le volume extracellulaire est augrnenté ou quand Ia reabsorption
active de sodium est inhibée par l'amiloride.
We [1] first proposed that the urine minus arterial blood Pco2
difference in alkaline urine (U-B Pco2) could be used as a
qualitative index of hydrogen ion secretion in the collecting
duct. Steinmetz, Al-Awqati, and Lawton [2] suggested that the
urine bicarbonate concentration might play an important role in
determining the magnitude of the U-B Pco2. Arruda et al [3, 4]
subsequently demonstrated that the U-B Pco2 was directly
related to the urine bicarbonate concentration, and we have
confirmed this observation [5]. To explain the correlation
between the U-B Pco2 and the urine bicarbonate concentration,
Arruda et al [3, 4] have proposed that the urine bicarbonate
concentration plays a primary role in determining the urine
Pco2 and, as such, is largely responsible for generating the U-B
Pco2. They adapted the suggestion of Maren [6] that the
'ampholyte" property of bicarbonate led to carbon dioxide
generation via the following reaction: 2 HCO — H2C03 +
CO. But, although there is often a correlation between the U-
B Pco2 and the urine bicarbonate concentration, the physiolog-
ic basis for this correlation and its implications in interpreting
the U-B Pco2 as an index of collecting duct hydrogen ion
secretion remain controversial.
In more recent studies in our laboratory in which we studied
dogs without substantial extracellular fluid (ECF) volume ex-
pansion, we observed that the U-B Pco2 was much higher at
any given urine bicarbonate concentration than it was in our
previous studies [5]. Furthermore, we were not able to demon-
strate the previously well-documented correlation between the
U-B Pco2 and the urine bicarbonate concentration. Therefore,
the purpose of this investigation was to systematically reevalu-
ate the relationship between the U-B Pco2 and the urine
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bicarbonate concentration. Our results indicate that in dogs
with minimal ECF volume expansion, the U-B Pco2 correlates
best with the rate of sodium excretion, whereas in dogs with
substantial ECF volume expansion, this correlation disappears.
Under these conditions, and following amiloride administra-
tion, the U-B Pco2 correlates with the urine bicarbonate
concentration. The implications of these studies for physiologic
factors that control collecting duct hydrogen ion secretion in
vivo are discussed.
Methods
Experiments were performed on 20 mongrel dogs ranging in
weight from 10 to 20 kg. The dogs were anaesthetized with i.v..
sodium pentobarbital (30 mg/kg of body wt), and 20- to 40-mg
doses were added whenever necessary. An endotracheal tube
was introduced into the trachea, and polyethylene catheters
were inserted into the femoral artery and vein. Urine was
collected through ureteral catheters and analyzed for pH and
Pco2 at 10-mm intervals, and collections were made for 30-mm
periods as previously described [5, 7—9]. Two different proto-
cols were used in these studies to produce bicarbonaturia in
dogs with an expanded or normal ECF volume.
Group I: Dogs with an expanded ECF volume. This group
consisted of 11 dogs infused with 0.7 M sodium bicarbonate at
an initial rate of 3 mI/mm for 30 mm, and this was followed by
an infusion rate of 1 to 2 mI/mm for the remainder of the
experiment. After an additional 90 mm, amiloride was adminis-
tered in 7 of these dogs as an initial bolus of 1 mg/kg of body wt
over 5 mm, and this was followed by an infusion of 2.4 mg/kg!
hr.
Group 2: Dogs with a normal ECF volume. This group
consisted of 9 dogs infused with isotonic sodium bicarbonate
throughout the experiment at a rate that ranged between 0.2 to
1.0 ml/min, which was approximately equal to the urine flow
rate. Care was taken to avoid studying animals with ECF
100 200 300
volume contraction because we have recently demonstrated
that the U-B Pco2 expressed as a function of the rate of sodium
excretion is much higher in these dogs (Tam et al, unpublished
observations). In 7 of these dogs, amiloride was administered as
described above.
The pH and Pco2 of arterial blood and freshly collected uLrine
were measured anaerobically at 37° C with a digital acid-base
analyzer (Radiometer, model pHM 72). The bicarbonate con-
centration was calculated as previously described [5, 7—9],
using the solubility factor of 0.0301 for plasma and 0.0309 for
urine. The concentrations of sodium and potassium in bl[ood
and urine were determined by flame photometry with a flame
photometer (Radiometer, model FLM3). Chloride was rnea-
sured with a chloride titrator (Radiometer, model CMT1O).
Urine buffer capacity was measured by the back-titration of
bicarbonate-free urine with sodium hydroxide (0.01 N), and the
GFR was measured by the clearance of 3H-inulin. Regression
lines were calculated by the method of least squares.
200
I
A
S
S
0
C)
..
•.
*
—. • . •1•
.'4.
•.. i••
200 300
80 -
SS
A40-
0
80- B
S
S
40
UHCO mM
Fig. 1. Effect of the urine bicarbonate concentration on the U-B Pco2 in
dogs infused with isotonic sodium bicarbonate. For details, see meth-
ods section. The increase in ECF volume ranged from 0 to 20% based
on sodium balance data. Each point represents a single collection from
individual dogs. The total number of animals was ten.
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Fig. 2. Effect of sodium excretion (A) and urine bicarbonate concntra-
tion (B) on the U-B Pco2 in dogs with an expanded ECF volume. For
details see methods section. The regression line between the U-B Pco2
and UNaV was U-B Pco2 = —0.006 UNV + 58, N = 29, r = 0.13, and
that between the U-B Pco2 and the urine bicarbonate concentration is
U-B Pco2 = 0.19 UHCO + 15, N = 29, r = 0.83, P < 0.01.
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Table 1. Acid-base and electrolyte composition in normal dogs infused with a large sodium bicarbonate load'
GFR
mi/mm
38
49
GFR
mi/mm
46
49
Blood
20 148
32 156
33 157
Blood and urine values
FE1
0.56
0.06
1.1
V
mI/mm
79
105
Na balance
mEq
4.8
1,7
BC mEqi
liter! pH
unit
U-B Pco2
mm Hg
50
44
U-B Pco2
mm Hg
92
52
Results
In a pilot series of ten experiments, the previously docu-
mented relationship between the U-B Pco2 and the urine
bicarbonate concentration was not observed (Fig. 1). The blood
pH ranged between 7.35 and 7.50, but there were marked
differences in the ECF volumes in these animals (from 0 to 20%
gain in the ECF volume as judged by cumulative sodium
balance data during the acute experiment). The data from these
10 and an additional 10 animals were divided into two groups on
the basis of their ECF volume.
Group 1: Dogs with an expanded ECF volume (Table I).
Hypertonic sodium bicarbonate infusion resulted in a marked
Pco2
pH mmHg
HCO3 Na K Cl
mEqiliter
UNaV
.i.Eq/min
3.8
3.3
3.8
Before infusion 7.37 36
During infusion 7,49 44
After amiloride 7.51 44
During infusion 7.89 95
After amiloride 7.98 89
During infusion
After amilonde
120
112
116
Urine
203 247 45 47 2.1 3.6 497
±11 ±9 ±7 ±4 ±0.2 ±0.8 ±43
231 292 5 32 2.4 2.2 702
±8 ±9 ±1 ±5 ±0.2 ±0.2 ±46
Blood and urine values
FEc1
2.6
±0.4
1.4
±0.2
Na balance
mEq
a BC is buffer capacity; S', flow rate; FE, fractional excretion. For details, see methods section. Results are reported as the mean ± SEM for 11
dogs.
Table 2. Acid-base and electrolyte composition in normal dogs infused with isotonic sodium bicarbonate solution
HCO3 Na K
Pco2 .
pH mm Hg
-
mEq!liter
Cl
V
mI/mm
-
BC mEqi
liter! pH
unit
UNaV
i.Eq/min
Before infusion 7.36 40
±0.01 ±2
During infusion 7.39
±0.01
39
±1
After amiloride 7.43
±0.01
35
±1
During infusion 7.69
±0.03
After amiloride 7.85
±0.04
During infusion
After amiloride
Blood
22 149 3.7 117
±1 ±2 ±0.1 ±1
23 151 3.7 118
±1 ±1 ±0.1 ±1
23 150 4.2 116
±1 ±1 ±0.1 ±1
131 221
Urine
325 182 118 0.25 18 82
±7 ±16 ±13 ±9 ±14 ±0.01 ±2 ±5
88 215 390 II 83 0.87 12 297
±4 ±16 ±17 ±3 ±7 ±0.14 ±2 ±36
a BC is buffer capacity; ', flow rate; FE, fractional excretion. For details, see methods section. Results are reported as the mean ± SEM for 9
dogs.
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Fig. 3. Effect of sodium excretion (A) and urine bicarbonate concentra-
tion (B) on the U-B Pco2 in normal dogs. Each point represents the
average of three individual determinations taken at 10-mm intervals.
The urine pH of consecutive samples differed by less than 0.1 unit. The
regression line between the U-B Pco2 and sodium excretion is U-B
Pco2 = 1.1 UNaV — 0.6, N = 29, r = 0.75, P < 0.01, and that between
the U-B Pco2 and the urine bicarbonate concentration was U-B Pco2
0.08 UHcO, + 77, N = 27, r = 0.17.
expansion of the ECF volume as judged from sodium balance
data during the acute experiment. The U-B Pco2 did not
correlate with the absolute rate of sodium excretion (Fig. 2A),
but there was a correlation with the urine bicarbonate concen-
tration (Fig. 2B) as previously noted [3—5].
Group 2:Dogs with a normal ECF volume. To eliminate ECF
volume expansion as a factor that might influence the U-B
Pco2, we selected dogs for this group because they had, on the
average, less than 2% expansion of the ECF volume as reflected
by sodium balance data during the acute experiment. The
sodium gain ranged from Ito 30 mEq with a mean SEM of 4.8
1.4 mEq. Fractional chloride excretion was much lower and the
U-B Pco2 was much higher in these dogs. Dogs receiving the
smaller bicarbonate infusion had a lower blood pH, Pco2,
bicarbonate and sodium concentration, as well as a higher
chloride concentration. The urine pH, flow rate, and sodium
excretion rate were lower, whereas the urine Pco2, sodium,
potassium, chloride, and buffer capacity were significantly
higher in these dogs (compare Tables I and 2). There was a
good correlation between the U-B Pco2 and the rate of sodium
excretion (Fig. 3A), whereas the U-B Pco2 correlated poorly
with urine bicarbonate concentration (Fig. 3B) in these dogs.
The absolute rate of sodium excretion should be the best in vivo
indicator of sodium delivery to the collecting duct because
bicarbonate was the predominant accompanying anion, and it is
largely nonresorbable in this nephron segment. Furthermore,
the U-B Pco2 did not correlate significantly with the urine
sodium or potassium concentration or the rate of bicarbonate
excretion in these studies.
Dogs infused with amiloride. When amiloride was adminis-
tered to the dogs with a normal ECF volume, positive sodium
balance decreased to 1.7 2,8 mEq due to enhanced sodium
excretion. At low urine bicarbonate concentrations (25 to 75
mEq/liter), the U-B Pco2 decreased from 62 7 to 5 1 mm Hg
(Fig. 4). The urine potassium concentration fell from 182 9 to
II 3 mEq/liter after amiloride. At higher urine bicarbonate
concentrations (100 to 400 mEq/liter), a substantial decrease in
the U-B Pco2 was observed (from 92 7 to 51 2 mm Hg)
Fig. 4. Effect of amiloride on the U-B Pco2 in normal dogs. Data were
selected such that the urine bicarbonate concentration ranged between
25 and 100 m, and the animals remained in steady-state as defined in
the results section. Open circle (0) denotes no amiloride; closed circle
(•), with amiloride.
when the urine bicarbonate was approximately 200 mEq/l][ter,
and the U-B Pco2 now correlated significantly with the urine
bicarbonate concentration (Fig. 5). The slope depicting this
relationship was the same as it was in animals with an expanded
ECF volume, but the intercept was significantly lower after
amiloride. In contrast, the effect of amiloride on the U-B Pco2
was quite small in alkalemic dogs with an expanded ECF
volume and similar blood pH values (Fig. 6). The urine potassi-
um concentration declined from 45 7 to 5 I mEq/liter after
amiloride administration in these dogs.
Discussion
General fratures of hydrogen ion secretion in models of the
mammalian collecting duct (Fig. 7). Much of the information
about the secretion of hydrogen ions by renal tubular cells has
been derived from studies on reptilian and amphibian urinary
bladders. These bladders and collecting duct cells have a similar
embryologic origin, and the bulk of evidence suggests that they
have similar secretory and permeability characteristics. Hydro-
gen ion secretion in these membranes occurs by a pathway hat
is independent of that for sodium and depends on the integrity
of a proton-specific pump that is influenced by intracellular pH,
Pco2, and aldosterone. One can quantitate the basal hydrogen
ion secretion in these bladders when sodium is removed from
the lumenal fluid, when sodium transport is blocked by pharma-
cologic agents or when the development of a potential differ-
ence by active sodium transport is prevented by "short-circuit-
ing" the bladder preparation. In these cases, hydrogen ion
secretion is increased when the intracellular hydrogen ion
concentration is increased or the lumenal one decreased for
review, see Refs. 10—14).
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Because sodium reabsorption is critical for the generation of
the electrical gradient that augments the hydrogen ion secretory
process, we will summarize succinctly the principal factors
determining sodium reabsorption in the collecting duct. The
major factor that governs sodium reabsorption in this nephron
segment is the rate of sodium delivery because reabsorption is
mostly "load dependent" (for review, see Ref. 15). Another
factor that appears to play a role in governing sodium reabsorp-
tion is the so-called "avidity" of the tubules for sodium. It
appears that significant expansion of the ECF volume will
decrease the avidity for sodium reabsorption in this nephron
segment [151. Other factors influence the magnitude of the
electrical gradient that is generated when sodium is reabsorbed.
The most important of these is the impermeability of the anions
delivered along with sodium to the distal nephron [161. It should
also be noted that under certain conditions, the ability of this
membrane to maintain a large electrochemical gradient for
hydrogn ions may be compromised [17—211.
Influence of the rate of sodium excretion on the U-B Pco2.400 With the above principles in mind, we have reevaluated factors
determining the U-B Pco2, an index of collecting duct hydrogen
ion secretion [I]. As shown in Fig. 3B, the U-B Pco2 in
normovolemic dogs did not correlate significantly with the urine
bicarbonate concentration but rather was related to the rate of
distal sodium delivery as reflected by the rate of sodium
excretion, for reasons discussed in the results section. These
data are compatible with but do not prove that an electrical
augmentation of collecting duct hydrogen ion secretion is
important under these conditions.
In contrast, the protocol used for the U-B Pco2 measure-
ments in our earlier studies [51 resulted in a substantial expan-
sion of the ECF volume as judged by the fractional excretion of
chloride and by sodium balance data. It was not unusual to have
a 20% increase in this volume (0.7 M sodium bicarbonate
infused at I to 2 mI/mm for up to 4 hours). Although sodium
balance data were not reported in the studies of Arruda et al [3,
4], they also infused very large sodium loads and reported
similar excretion rates for sodium, chloride, and bicarbonate.
One would predict that during marked ECF volume expansion,
there should be a much smaller degree of stimulation of sodium
reabsorption in the collecting duct [15], hence the lack of
correlation between the U-B Pco2 and the rate of sodium
—i excretion and the much lower absolute values for the U-B Pco2
(Figs. 2 and 3).
Urine Bicarbonate Concentration and the U-B Pco,. The
influence of the urine bicarbonate concentration on the U-B
Pco2 requires further consideration. It has been suggested that
bicarbonate could increase the urine Pco2 independent of
hydrogen ion secretion due to its ampholyte property [3, 6].
Should this be the case, one would expect a predictable linear
relationship between the Pco2 and bicarbonate concentration in
the urine. But, this predictable relationship does not invariably
occur (Fig. 1). Other data are also hard to reconcile within the
ampholyte hypothesis. First is the observation of Giammarco et
a! [22] that normal rabbits do not develop a large U-B Pco2 as
predicted by the ampholyte hypothesis. Second is the observa-
tion of Gougoux et al [71 that dogs with lysine-induced proximal
renal tubular acidosis have a threefold steeper slope in the
linear relationship between the U-B Pco2 and the urine bicar-
bonate concentration during acidemia as compared with alkale-
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Fig. 5. Effect of the urine bicarbonate concentration on the U-B Pco2 in
the presence of amiloride in normal dogs. The regression line is U-B
Pco2=0.l8UHco— 14,N65,r=0.76,P<Q.O1,
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Fig. 6. Effect of urine bicarbonate concentration on the U-B Pco2 in the
absence (0) and the presence (S) of amiloride in dogs with an
expanded ECF volume. The regression line without amilonde is U-B
Pco2 = 0.12 UHCO3 + 25, N = 47, r = 0.68, P < 0,01, and with
amiloride is U-B Pco2 = 0.20 UHCO = 2.3, N = 60, r = 0.75, P < 0.01.
This hydrogen ion secretory process can also be modified by
sodium reabsorption. Active sodium reabsorption generates a
"lumen-negative" potential difference in bladder preparations
or perfused collecting ducts, and this will lead to an augmenta-
tion of hydrogen ion secretion. We shall refer to this increment
as the electrical augmentation of hydrogen ion secretion. It is
abolished by removing sodium from the lumenal fluid or inhibit-
ing sodium reabsorption by ouabain, amiloride, and lithium (for
review, see Refs. 10—14).
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mia. Third are our observations [1, 171 that patients with distal
renal tubular acidosis do not increase the U-B Pco2 with
increasing urine bicarbonate concentrations. These data and
theoretical considerations discussed previously [5] led us to
suggest that the linear relationship between the U-B Pco2 and
the urine bicarbonate concentration that is observed during
ECF volume expansion is due to other factors and that the
ampholyte effect of bicarbonate is not a significant determinant
of the U-B Pco2 in any in vivo condition that has been carefully
studied.
By what mechanism does an increase in the urine bicarbonate
concentration raise the U-B Pco2? When the mucosal hydrogen
ion concentration gradient is very high, the magnitude of net
proton secretion is much lower in the isolated turtle bladder, art
"in vitro" model of the collecting duct [10, 11]. Because the
intralumenal pH should be more alkaline in fluid with very high
bicarbonate concentrations, by analogy, this could lead to a
higher rate of net hydrogen ion secretion for any given stimulus
and therefore a higher U-B Pco2. During ECF volume expan
sion, the sodium-dependent augmentation of collecting duct:
hydrogen ion secretion should be minimized making the rela-
tionship between the U-B Pco2 and urine bicarbonate concen
tration evident (Fig. 2B). Whether or not a similar mechanism is
operative in normovolemic dogs could not be determined in the
studies reported in Fig. 3A because the rate of sodium delivery
and excretion and not the urine bicarbonate concentration was
the predominant factor determining the U-B Pco2 at this time.
Studies with amiloride: (a) Dogs with ECF volume expan
sion. Amiloride abolishes the lumen-negative transtubular p0-
tential difference. It also leads to a decrease in collecting duct
hydrogen ion secretion [23—28]. As amiloride may have other
effects in the collecting duct in addition to the above [29], we
shall define that fraction of the U-B Pco7 that is abolished by
amiloride as the amiloride-sensitive component of the U-B
Pco2. When this drug was infused into dogs with an expanded
ECF volume, there was little decline in the U-B Pco2 at any
given urine bicarbonate concentration (Fig. 6). There semed to
be a similar degree of pharmacologic action of amiloride in all
groups as the marked falls in the urine potassium concentration
were comparable (see Tables I and 2). This suggests that the
amiloride-sensitive component of the U-B Pco2 was of minor
importance when the ECF volume was substantially expanded.
We suggest that the lack of effect of amiloride in these condi-
tions is due to previous depression of collecting duct sodium
reabsorption by ECF volume expansion, but other effects of
amiloride cannot be excluded.
(b) Normovoleinic dogs. When amiloride was administered
to normovolemic dogs excreting a urine containing 25 to 75 mrvi
bicarbonate, the U-B Pco2 fell virtually to zero (Fig. 4),
supporting the concept that hydrogen ion secretion in the
collecting duct was almost exclusively an amiloride-sensitive
mechanism [5] in the absence of ECF volume expansion and a
high urine bicarbonate concentration. In normovolemic dogs
excreting urine with high bicarbonate concentrations, amiloride
caused the U-B Pco2 to fall significantly, and there was now a
linear correlation between the U-B Pco2 and the urine bicarbon-
ate concentration (Fig. 5). The slope depicting this relationship
was similar to that in dogs with an expanded ECF volume, but
the intercept was somewhat lower. These results suggest that
the low lumenal hydrogen ion concentration favored collecting
Electrtcal ChemicaL
Fig. 7. Factors influencing acid excretion by the collecting duct. For
description, see text. As shown on the left side of the upper panel, the
proton pump actively secretes hydrogen ions (H), and the activity of
this pump can be increased by mineralocorticoids. In the left lower
panel, electrical factors should normally augment collecting duct hydro-
gen ion secretion when there is a high rate of sodium delivery, a
stimulus for sodium reabsorption, and a high delivery rate of nonresorb-
able anions. Amiloride and lithium are agents that decrease the electri-
cal gradient. The chemical factors that may augment hydrogen ion
secretion include acidemia, which presumably increases the ICF hydro-
gen ion concentration, and urine buffers, which decrease the lumenal
hydrogen ion concentration.
duct hydrogen ion secretion but it can only be observed in
normovolemic dogs excreting urine with a high bicarbonate
concentration once the amiloride sensitive component was
abolished by this drug. Again, these results are compatible with
but do not establish that the enhanced effect of amiloride on the
U-B Pco2 is due to pronounced electrical augmentation of
hydrogen ion secretion under these conditions.
Otherfactors that might influence the magnitude of the U-B
PCO2. A decrease in the blood Pco2 can lead to a fall in the U-B
Pco2 [30], but in the dogs with an expanded ECF volume
reported in this article, the blood Pco2 was higher. Although
hypokalemia can lead to a decrease in the U-B Pco2 in the
rabbit [22], the U-B Pco2 was not influenced by changes in the
plasma potassium concentration in the dog [4], hence the results
reported here in dogs cannot be attributed to the small differ-
ences in the plasma potassium concentration. Alkalemia causes
the U-B Pco2 to fall [71. But, over this narrow alkalemic pH
range, the changes in the U-B Pco2 due to this parameter would
be too small to account for the large differences reported in the
U-B Pco2. Although the urine buffer capacity is important to
generate a high U-B Pco2, changes in the range reported in
Tables 1 and 2 were not of the magnitude that have been shown
to influence the U-B Pco2 when the urine bicarbonate concen-
tration exceeds 120 mis't [5]. Last, although the urine flow rate
was higher in the dogs receiving the larger sodium bicarbonate
load, there is no evidence that flow rate influences the U-B
Pco2 when this parameter is analyzed independent of the urine
bicarbonate concentration [31, 32].
In summary, in the normovolemic state, the magnitude of the
U-B Pco2 is directly related to the rate of sodium excretion.
But, when the ECF volume is expanded, the U-B Pco2 is no
longer related to the rate of sodium excretion, and at this time,
there is a good correlation between the U-B Pco2 and the urine
Acitemia
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bicarbonate concentration. Presumably, in the nonexpanded
state, sodium delivery and avidity are important whereas in the
expanded state the chemical factors assume a relatively more
important role. The data presented are consistent with the
hypothesis that hydrogen ion secretion in the collecting duct is
an active process, the magnitude of which can be increased by
either a favorable electrical gradient or a decrease in the
hydrogen ion concentration gradient across the lumenal mem-
brane. This hypothesis, however, must be considered tentative
until direct measurements of collecting duct potential difference
under these conditions can be obtained.
Acknowledgments
This work was supported by an Annual Grant (MA-5623) from the
Medical Research Council of Canada and the St. Michael's Hospital
Research Society. Dr. Tam is a postdoctoral research fellow of the
Canadian Heart Foundation. We acknowledge the assistance of Ms. B.
Gardner.
Reprint requests to Dr. M. L. Ha/penn, St. Michael's Hospital, Lab
#1, Research Wing, 38 Shuter Street Annex, Toronto, Ontario, Cana-
da, M5B lAb
References
I. HALPERIN ML, GoLDsTEIN MB, HAlO A, JOHNSON MD,
STINEBAUGH BJ: Studies on the pathogenesis of type (distal) renal
tubular acidosis as revealed by the urinary Pco2 tensions. J C/in
Invest 53:669—677, 1974
2. STEINMETZ PR, AL-AWQATI Q, LAWTON Wi: Specialty rounds:
Renal tubular acidosis. Am J Med Sci 271:40—54, 1976
3. ARRUDA JAL, NASCIMENTO L, MEHTA PK, RADEMACHER DR,
Sri-jy iT, WESTENFELDER C, KURTZMAN NA: The critical impor-
tance of urinary concentrating ability in the generation of urinary
carbon dioxide tension. J C/in Invest 60:922—935, 1977
4. ARRUDA JAL, NASCIMENTO L, KUMAR SK, KURTZMAN NA:
Factors influencing the formation of urinary carbon dioxide ten-
sion. Kidney mt 11:307—317, 1977
5. STINEBAUGH BJ, ESQUENAZI R, SCHLOEDER FX, SUKI WN,
GOLDSTEIN MB, HALPERIN ML: Control of the urine-blood Pco,
gradient in alkaline urine. Kidney lnt 17:31—39, 1980
6. MAREN TH: Carbon dioxide equilibria in the kidney: The problems
of elevated carbon dioxide tension, delayed dehydration, and
disequilibrium pH. Kidney mt 14:395—405, 1978
7. Gouooux A, VINAY P. LEMIEUX G, RICHARDSON RMA. TAM SC,
GOLDSTEIN MB, STINEBAUGJ-I BJ, HALPERIN ML: Effect of blood
pH on distal nephron hydrogen ion secretion. Kidney lot 17:615—
621, 1980
8. RoscoE JM, GOLDSTEIN MB, HALPERIN ML, WILSON DR,
STINEBAUGH Bi: Lithium-induced impairment of urine acidifica-
tion. Kidney mt 9:344—350, 1976
9. TAM SC, GOLDSTEIN MB, RICHARDSON RMA, ROBSON WLM,
STINERAUGH BJ, HALPERIN ML: Effect of extracellular fluid
volume contraction on distal nephron hydrogen ion secretion in
vivo. J Lab C/in Med 96:442—449, 198(1
10. STEINMETZ PR: Cellular mechanisms of urinary acidification. Phv-
siol Rev 54(4):890—956, 1974
11. STEINMETZ PR: Characteristics of urinary acidification in the distal
nephron, in Proc VII lot Cong Nep/zrol, New York, S. Karger,
1978, pp 329—336
12. AL-AWQATI Q: W transport in urinary epithelia. Am J Phvsio/
235(2):F77—F88, 1978
13. WARNOCK DG. RECTOR FC JR: Proton secretion by the kidney.
Ann Rev Phvsio/ 41:197—210, 1979
14. KURTZMAN NA: "Short-circuit" renal tubular acidosis. fLab C/in
Med 95:633—636. 1980
15. JAMISON RL, SONNENBERG H, STEIN JH: Questions and replies:
role of the collecting tubule in fluid, sodium and potassium balance.
Am J Physio/ 237(4):F247—261, 1979
16. SCHWARTZ WB, JENSON RL, RELMAN AS: Acidification of the
urine and increased ammonium excretion without change in acid-
base equilibrium: Sodium reabsorption as a stimulus to the acidify-
ing process. J C/in Invest 34:673—680, 1955
17. STINEBAUGH BJ, SCI-ILOEDER FX, TAM SC, GOLDSTEIN MB,
HALPERIN ML: The pathogenesis of distal renal tubular acidosis.
Kidney Int 19:1—7. 1981
18. STEINMETZ PR, LAWSON LR: Defect in urinary acidification in-
duced in vitro by amphotericin B. J C/in Invest 49:596—601, 1970
19. ROSCOE JM, GOLDSTEIN MB, HAII'ERIN ML, SCHLOEDER FX,
STINEBAUGH BJ: Effect of amphotericin B on urine acidification in
rats: Implications for the pathogenesis of distal renal tubular
acidosis. J La!, C/in Med 89:463—470, 1977
20. JULKA NK, ARRUDA JAL. KURTZMAN NA: The mechanism of
amphotericin-induced distal acidification defect in rats. C/in Sci
56:555—562, 1979
21. GARG LC: Lack of effect of amphotericin B on urine-blood Pco,
gradient in spite of urinary acidification defect. Pflueger.s Ale/I
381:137—142. 1979
22. GIAMMARCO RA, GOLDSTEIN MB. HAIPERIN iS, HAMMEKF. MD.
RICHARDSON RMA, ROBsON WLM. STINEBAUGI-I Bi, HALPERIN
ML: Collecting duct hydrogen ion secretion in the rabbit: Role of
potassium. J Lab ('ii,, Med 91:948—959, 1978
23. DUARTE CG, CHOMETY F, GIERISCH G: Effect of amiloride,
ouabain, and furosemide on distal tubular function in the rat. Am J
Physio/ 221:632—639, 1971
24. STONER LC, BURG MB. ORLOFF J: Ion transport in cortical
collecting tubule: Effect of amiloride. A,n J Physio! 227:453—459,
1974
25. ZIEGLER TW, FANESTIL DD, LUDENS ill: Influence oftransepithe-
hal potential difference on acidification in the toad urinary bladder.
Kidney lot 10:279—286, 1976
26. HUSTED RF, STEINMETZ PR: The effects of amiloride and ouabain
on urinary acidification by turtle bladder. J Plwrmaco/ Exp Ther
210:264—268, 1979
27. ULLRIcn Ki, PAPAVASSII.IOU F: Sodium reabsorption in the papil-
lary collecting duct of rats: Effect of adrenalectomy. low Na' diet,
acetazolamide, HC() -free solutions and of amiloride. Pfluegers
Arch 379:49-52, 1979
28. ARRUDA JAL, SUBBARAYUDU K, DYTKO G. MOLA R, KURTZMAN
NA: Voltage-dependent distal acidification defect induced by ami-
bride. J Lab C/in Med 95:407—416, 1980
29. MCKINNEY TD. BURG MB: Bicarbonate absorption by rabbit
cortical collecting tubules in vitro, Am J Pht'sio/ 234(2):F141—F145.
1978
30. GIAMMARCO RA, GOlDSTEIN MB. HALPERIN ML, STINEBAUGI-1
BJ: The effect of hyperventilation on distal nephron hydrogen ion
secretion. J Cliri Inve.s't 58:77—82, 1976
31. STINEBAUGH BJ, HOSTETTER TH, PERAINO RA, SCHLOFDERFX,
SUKI WN: Lack of dependence of urine PC02 upon reduction of
gbomerular tiltration rate in alkabotic dogs. C/in Sci Mo! Med
52:119—123, 1977
32. PEREZ GO, OSTER JR. SONNERORN RE. CASSADY J, VAAMONDE
CA: Analysis of variables influencing urinary Pco, during NaHCO
and water loading in normal man (39999). Proc Soc Exp Bio! Med
157:97—102, 1978
